PharmaDiscovery 2005 - May 10-12, 2005 - Washington, DC

PharmaDiscovery 2005
May 10-12, 2005 - Washington, DC
Washington, DC Convention Center
Why is the PharmaDiscovery Conference different than most?
The conference program has been developed by chairs and co-chairs to actively encourage scientific debate and audience participation. Presentations, led by scientists, will focus on clear objectives and tackle key issues within each discipline. The conference will have daily sum-up sessions that will integrate and disseminate scientific knowledge, and relay the key points and conclusions from each session back to the entire audience, facilitating the exchange of information between chemists and biologists, and helping to break down drug discovery silos.
Take a look at some of your colleagues who have already registered to attend:
Associate Professor, Harvard University
Chief Scientific Officer, Novasite Pharmaceuticals
Chief Technology Officer, Vertex Pharmaceuticals
Director of Drug Discovery, Bristol Myers Squibb
Director of Mechanistic Toxicology, Johnson and Johnson
Director, Pre-Clinical Drug Metabolism, Merck
Scientific Disciplines.
This scientific conference will maximize networking opportunities amongst industry leaders from pharma, biotech and academic communities, regulatory authorities, and developers of critical technologies.